Skip to content
value.today

Astute Medical, Inc.

Total raised
$167 M
9 rounds on record
Latest round
$43 M
Dec 2016
First round on record
May 2010
Today
Private
No later event on record

Funding rounds

9 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Astute Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2016$43 MNo. 9$10 to $50 million

Astute Medical, Inc.: Raise no. 9, Dec 2016

Investors in this round

18 investors had bought by the notice of Dec 16, 2016: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$43 M of $43 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • James Scopa · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • PIPER JAFFRAY & CO. (CRD 665) · Minneapolis, MinnesotaSold in MN

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Dec 16, 2016. Read the notice at the SEC.

equitySEC
Nov 2016$3 MNo. 8$2 to $10 million

Astute Medical, Inc.: Raise no. 8, Nov 2016

Investors in this round

17 investors had bought by the notice of Dec 2, 2016: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • James Scopa · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold includes principal amount of convertible notes and purchase price of warrants; exercise price of warrants not determinable as of the date hereof.”

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Dec 2, 2016 (1 amendment). Read the notice at the SEC.

debt, optionsSEC
Sep 2015$20 MNo. 7$10 to $50 million

Astute Medical, Inc.: Raise no. 7, Sep 2015

Investors in this round

1 investor had bought by the notice of Oct 14, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $28 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • James Scopa · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Oct 14, 2015. Read the notice at the SEC.

equitySEC
Jul 2014$20 MNo. 6$10 to $50 million

Astute Medical, Inc.: Raise no. 6, Jul 2014

Investors in this round

35 investors had bought by the notice of Jul 29, 2014: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • James Scopa · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Jul 29, 2014. Read the notice at the SEC.

equitySEC
Jan 2014$5 MNo. 5$2 to $10 million

Astute Medical, Inc.: Raise no. 5, Jan 2014

Investors in this round

31 investors had bought by the notice of Mar 4, 2014: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • James Scopa · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold includes principal amount of convertible notes and purchase price of warrants; exercise price of warrants not determinable as of the date hereof.”

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Mar 4, 2014 (1 amendment). Read the notice at the SEC.

debt, optionsSEC
Jun 2012$40 MNo. 4$10 to $50 million

Astute Medical, Inc.: Raise no. 4, Jun 2012

Investors in this round

34 investors had bought by the notice of Jun 14, 2012: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $40 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • James Scopa · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Jun 14, 2012. Read the notice at the SEC.

equitySEC
May 2012$2 MNo. 3$2 to $10 million

Astute Medical, Inc.: Raise no. 3, May 2012

Investors in this round

14 investors had bought by the notice of May 25, 2012: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold includes principal amount of convertible notes and purchase price of warrants; exercise price of warrants not determinable as of the date hereof.”

Signed by Todd Myers, Chief Financial Officer. Newest notice filed May 25, 2012. Read the notice at the SEC.

debt, optionsSEC
Mar 2011$7 MNo. 2$2 to $10 million

Astute Medical, Inc.: Raise no. 2, Mar 2011

Investors in this round

22 investors had bought by the notice of Mar 9, 2011: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $13 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • Todd Myers · Executive Officer
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Todd Myers, Chief Financial Officer. Newest notice filed Mar 9, 2011. Read the notice at the SEC.

equitySEC
May 2010$27 MNo. 1$10 to $50 million

Astute Medical, Inc.: Raise no. 1, May 2010

Investors in this round

23 investors had bought by the notice of May 17, 2010: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $27 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hibberd · Executive Officer, Director
  • Paul McPherson · Executive Officer, Director
  • David Douglass · Director
  • Frederick Dotzler · Director
  • James Blair · Director
  • Kenneth Buechler · Director
  • Kim Blickenstaff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Hibberd, President and Chief Executive Officer. Newest notice filed May 17, 2010. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Astute Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2016).

    SEC Form D · Dec 2016

  • The industry group it chose in its notices: Other.

    SEC Form D · Dec 2016

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Astute Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Astute Medical, Inc.
NameRoleNamed in
Christopher HibberdExecutive officerDec 2016
Paul McPhersonExecutive officerDec 2016
Todd MyersExecutive officerDec 2016
Christopher HibberdDirectorDec 2016
David DouglassDirectorDec 2016
Frederick DotzlerDirectorDec 2016
James BlairDirectorDec 2016
James ScopaDirectorDec 2016
Kenneth BuechlerDirectorDec 2016
Kim BlickenstaffDirectorDec 2016
Paul McPhersonDirectorDec 2016